Russia may start trial of Covid-19 vaccine combining Sputnik V, Chinese shots: RDIF chief
- The Sputnik V vaccine is the first foreign-made vaccine to be approved in India and is currently being distributed in the country by Dr Reddy's Laboratories.
Russia may start trials on a vaccine combining its Sputnik V vaccine and various Chinese shots in Arab countries, the head of the Russian Direct Investment Fund (RDIF) told a news agency on Friday, according to Reuters. "These are the big manufacturers and it may be that we will start the first trials in Arab countries combining Sputnik with a number of Chinese vaccines," Kirill Dmitriev was quoted as saying by Interfax news agency.
A combination trial using the Sputnik V vaccine and the AstraZeneca jab has already been conducted and no negative side effects have been reported so far, Russian news agency Interfax reported.
Dmitriev also said Russia expects the World Health Organization (WHO) to approve the Sputnik V vaccine within two months. He said the European Medicines Agency (EMA) which is also reviewing Sputnik V "was provided with all basic existing information, there is no critical remarks for now at all".
RDIF helped finance the production of the Sputnik V vaccine and also markets the shot around the world, and so far it has been approved for use in over 60 countries worldwide. EMA, WHO and the US Food and Drug Administration (FDA) are yet to approve the jab.
The Sputnik V vaccine is the first foreign-made vaccine to be approved in India and is currently being distributed in the country by Dr Reddy's Laboratories. On Thursday, the Serum Institute of India (SII) applied for a test license to manufacture Sputnik V in the country.
RDIF claims that Sputnik V demonstrates the efficacy of 79.4 per cent when administered in a single dose and 91.6 per cent when administered in two doses. However, many US universities have asked students to get re-vaccinated with a WHO-approved vaccine if they have been administered Sputnik or India’s Covaxin, before colleges in the US open for the fall semester, news agency ANI reported on Friday.
The U.S. Centers for Disease Control and Prevention on Friday published recommendations by its group of independent experts on a smallpox vaccine that limit its use to only people who work closely with viruses such as monkeypox. The publication of the vote by the CDC's Advisory Committee on Immunization Practices, which took place in November last year, formalizes the recommendations.
The U.S. Securities and Exchange Commission is looking into Tesla Chief Executive Officer Elon Musk's disclosure of his stake in Twitter Inc in early April, according to a letter the agency sent to him that month. Musk was offered a board seat shortly after his initial disclosure and has since gone on to attempt to buy the company outright in a $44 billion deal to take it private. An SEC spokesperson declined to comment.
Nearly 20 officers stood in a hallway outside of the classrooms during this week's attack on a Texas elementary school for more than 45 minutes before agents used a master key to open a door and confront a gunman, authorities said Friday.
Former Pakistani prime minister Imran Khan on Friday stormed out of a press conference in Peshawar after he was questioned by a journalist on his party Pakistan Tehreek-i-Insaaf's role in the social media, Pakistan website Geo TV reported. This comes a day after the former prime minister and several senior leaders were booked for arson and vandalism in Islamabad during Azadi March.
More than 20 countries across the globe have reported detections of Monkeypox cases so far taking the total tally to nearly 200, the World Health Organisation. It had reported its first infection on May 18. Canada: Canada has a total of 25 infections of Monkeypox. Spain: The European nation has so far logged 84 cases of disease. The number saw a significant rise on May 26 when the country logged 25 cases.